Long-term outcome of inflammatory bowel disease patients with deep remission after discontinuation of TNF-blocking agents

Pauliina Molander, Martti Farkkila, Helena Kemppainen, Timo Blomster, Airi Jussila, Harri Mustonen, Taina Sipponen

Tutkimustuotos: ArtikkelijulkaisuArtikkeliTieteellinenvertaisarvioitu

Alkuperäiskielienglanti
LehtiScandinavian Journal of Gastroenterology
Vuosikerta52
Numero3
Sivut284-290
Sivumäärä7
ISSN0036-5521
DOI - pysyväislinkit
TilaJulkaistu - 2017
OKM-julkaisutyyppiA1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä, vertaisarvioitu

Tieteenalat

  • 3121 Sisätaudit

Lainaa tätä

@article{a7fffa8f04354617bab170ae2b581bbb,
title = "Long-term outcome of inflammatory bowel disease patients with deep remission after discontinuation of TNF-blocking agents",
keywords = "Crohn's disease, ulcerative colitis, relapse, stopping, TNF alpha-antagonist, infliximab, adalimumab, CROHNS-DISEASE, INFLIXIMAB THERAPY, CLINICAL REMISSION, ULCERATIVE-COLITIS, BIOLOGICAL THERAPY, SINGLE-CENTER, FOLLOW-UP, MAINTENANCE, ANTIBODIES, RELAPSE, 3121 Internal medicine",
author = "Pauliina Molander and Martti Farkkila and Helena Kemppainen and Timo Blomster and Airi Jussila and Harri Mustonen and Taina Sipponen",
year = "2017",
doi = "10.1080/00365521.2016.1250942",
language = "English",
volume = "52",
pages = "284--290",
journal = "Scandinavian Journal of Gastroenterology",
issn = "0036-5521",
publisher = "TAYLOR & FRANCIS LTD",
number = "3",

}

Long-term outcome of inflammatory bowel disease patients with deep remission after discontinuation of TNF-blocking agents. / Molander, Pauliina; Farkkila, Martti; Kemppainen, Helena; Blomster, Timo; Jussila, Airi; Mustonen, Harri; Sipponen, Taina.

julkaisussa: Scandinavian Journal of Gastroenterology, Vuosikerta 52, Nro 3, 2017, s. 284-290.

Tutkimustuotos: ArtikkelijulkaisuArtikkeliTieteellinenvertaisarvioitu

TY - JOUR

T1 - Long-term outcome of inflammatory bowel disease patients with deep remission after discontinuation of TNF-blocking agents

AU - Molander, Pauliina

AU - Farkkila, Martti

AU - Kemppainen, Helena

AU - Blomster, Timo

AU - Jussila, Airi

AU - Mustonen, Harri

AU - Sipponen, Taina

PY - 2017

Y1 - 2017

KW - Crohn's disease

KW - ulcerative colitis

KW - relapse

KW - stopping

KW - TNF alpha-antagonist

KW - infliximab

KW - adalimumab

KW - CROHNS-DISEASE

KW - INFLIXIMAB THERAPY

KW - CLINICAL REMISSION

KW - ULCERATIVE-COLITIS

KW - BIOLOGICAL THERAPY

KW - SINGLE-CENTER

KW - FOLLOW-UP

KW - MAINTENANCE

KW - ANTIBODIES

KW - RELAPSE

KW - 3121 Internal medicine

U2 - 10.1080/00365521.2016.1250942

DO - 10.1080/00365521.2016.1250942

M3 - Article

VL - 52

SP - 284

EP - 290

JO - Scandinavian Journal of Gastroenterology

JF - Scandinavian Journal of Gastroenterology

SN - 0036-5521

IS - 3

ER -